← Leaderboards
Tal Kafri
University Of North Carolina Chapel Hill
$11,523,888
Attributed
$11,523,888
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,523,888 · 5
By mechanism
R01$11,052,950 · 3
R21$396,208 · 1
R56$74,730 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- John C Olsen$2,427,292
- Richard C Boucher$55,332,929
- Kyson Xiaohuai Chou$1,994,853
- Lawrence E Ostrowski$7,659,247
- Haiyan Fu$5,284,175
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyMediatingVectorGene DeliveryViral VectorIn VivoLentivirus VectorHepaticMouse ModelProductionCellsMutantGene Delivery SystemExhibitsFactor IxBaseImmune ResponseTransduction EfficiencyGene ExpressionIn VitroLaboratoriesLiverProtocols DocumentationTransgene Expression
Grant awards (29)
The circadian rhythm as a lentiviral vector restriction factor$722,551
R01 · FY2023 · HL · contact PI
The circadian rhythm as a lentiviral vector restriction factor$739,656
R01 · FY2022 · HL · contact PI
The circadian rhythm as a lentiviral vector restriction factor$755,206
R01 · FY2021 · HL · contact PI
The circadian rhythm as a lentiviral vector restriction factor$770,756
R01 · FY2020 · HL · contact PI
Nonintegrating Lentiviral Vectors Towards Clinical Trials$380,000
R01 · FY2019 · DK · contact PI
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background$758,060
R01 · FY2018 · HL · contact PI
Nonintegrating Lentiviral Vectors Towards Clinical Trials$380,000
R01 · FY2018 · DK · contact PI
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background$758,060
R01 · FY2017 · HL · contact PI
Nonintegrating Lentiviral Vectors Towards Clinical Trials$380,000
R01 · FY2017 · DK · contact PI
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background$758,060
R01 · FY2016 · HL · contact PI
Nonintegrating Lentiviral Vectors Towards Clinical Trials$380,000
R01 · FY2016 · DK · contact PI
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background$758,060
R01 · FY2015 · HL · contact PI
Nonintegrating Lentiviral Vectors Towards Clinical Trials$319,242
R01 · FY2014 · DK · contact PI
Nonintegrating Lentiviral Vectors Towards Clinical Trials$308,069
R01 · FY2013 · DK · contact PI
Nonintegrating Lentiviral Vectors Towards Clinical Trials$319,242
R01 · FY2012 · DK · contact PI
Nonintegrating Lentiviral Vectors Towards Clinical Trials$366,945
R01 · FY2011 · DK · contact PI
Episomal lenti vector for a humanized hemophilia mouse$260,319
R01 · FY2010 · DK · contact PI
Episomal lenti vector for a humanized hemophilia mouse$53,636
R01 · FY2010 · DK · contact PI
Episomal lenti vector for a humanized hemophilia mouse$262,949
R01 · FY2009 · DK · contact PI
Episomal lenti vector for a humanized hemophilia mouse$262,949
R01 · FY2008 · DK · contact PI
Episomal lenti vector for a humanized hemophilia mouse$268,315
R01 · FY2007 · DK · contact PI
Novel Viral Vector Delivery for Efficient ShRNA Expression$177,208
R21 · FY2007 · HL · contact PI
Novel Viral Vector Delivery Efficient ShRNA Expression$219,000
R21 · FY2006 · HL · contact PI
Episomal lenti vector for a humanized hemophilia mouse$74,730
R56 · FY2006 · DK · contact PI
LENTIVIRAL VECTOR BASED GENE THERAPY FOR LIVER DISEASES$218,250
R01 · FY2005 · DK
LENTIVIRAL VECTOR BASED GENE THERAPY FOR LIVER DISEASES$218,250
R01 · FY2004 · DK
LENTIVIRAL VECTOR BASED GENE THERAPY FOR LIVER DISEASES$218,250
R01 · FY2003 · DK
LENTIVIRAL VECTOR BASED GENE THERAPY FOR LIVER DISEASES$218,250
R01 · FY2002 · DK
LENTIVIRAL VECTOR BASED GENE THERAPY FOR LIVER DISEASES$217,875
R01 · FY2001 · DK